Colorectal Cancer Clinical Trials in Austin

Showing 101-120 of 136 trials

Observational Study of Sub-populations From Cologuard Post-Approval Study (2014-01)

NCT03705013

The primary endpoint is to obtain longitudinal information on four sub-populations from the Cologuard Post-Approval Study.

Colorectal Cancer

Exact Sciences Corporation51 participantsStarted Oct 2018

Glendale, Arizona, United States • Mesa, Arizona, United States • Tempe, Arizona, United States +17 more locations

COMPLETEDPHASE3< 1 mile

A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer

NCT00009737

This 2 arm study will compare the safety and efficacy of oral Xeloda, or 5-fluorouracil in combination with leucovorin, in patients who have undergone surgery for colon cancer. Patients will be randomized to receive either Xeloda 1250mg/m2 po bid on days 1-14 every 21 days, or leucovorin 20mg/m2 iv + 5-fluorouracil 425mg/m2 iv daily from day 1 to day 5 every 28 days. The anticipated time on study treatment is 3-12 months, and the target sample size is 500+ individuals.

Colorectal Cancer

Hoffmann-La Roche1,987 participantsStarted Nov 1998

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Fountain Valley, California, United States +130 more locations

Observational Study of Sub-populations From Cologuard Post-Approval Study (2014-01)

A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer

Colorectal Cancer Trials in Other Cities

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer

Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer

PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study

Study of Safety and Efficacy of Ribociclib and Trametinib in Patients With Metastatic or Advanced Solid Tumors

Combination Chemotherapy With or Without Chemoembolization in Treating Patients With Colorectal Cancer Metastatic to the Liver (6655)

Validation of Colon Biomarkers for the Early Detection of Colorectal Adenocarcinoma

Study of Ruxolitinib in Colorectal Cancer Patients

Vitamin D/Calcium Polyp Prevention Study

A Study of Capecitabine (Xeloda) and Bevacizumab as a First-line Therapy in Patients With Metastatic Colorectal Cancer

Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy

Sym004 vs Standard of Care in Subjects With Metastatic Colorectal Cancer

Paired Analysis of Sensitivity for Colorectal Cancer Using COLVERA : PASCAL

Screening Tests in Detecting Colorectal Cancer

Study of CS-7017 in Combination With FOLFIRI in Subjects With Metastatic Colorectal Cancer Who Failed First-Line Therapy

Sorafenib Tosylate, Bevacizumab, Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer

Vaccine Therapy in Treating Patients With Liver or Lung Metastases From Colorectal Cancer

Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy in Treating Patients Who Are Undergoing Surgical Resection for Locally Advanced Rectal Cancer

Other Conditions in Austin